IL146406A0 - Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions - Google Patents

Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Info

Publication number
IL146406A0
IL146406A0 IL14640600A IL14640600A IL146406A0 IL 146406 A0 IL146406 A0 IL 146406A0 IL 14640600 A IL14640600 A IL 14640600A IL 14640600 A IL14640600 A IL 14640600A IL 146406 A0 IL146406 A0 IL 146406A0
Authority
IL
Israel
Prior art keywords
octan
polymorphs
pharmaceutical compositions
amine citrate
azabicyclo
Prior art date
Application number
IL14640600A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL146406A0 publication Critical patent/IL146406A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14640600A 1999-06-01 2000-05-18 Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions IL146406A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01
PCT/IB2000/000665 WO2000073304A1 (en) 1999-06-01 2000-05-18 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL146406A0 true IL146406A0 (en) 2002-07-25

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14640600A IL146406A0 (en) 1999-06-01 2000-05-18 Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions

Country Status (49)

Country Link
US (1) US6255320B1 (ja)
EP (1) EP1181290B1 (ja)
JP (1) JP3830816B2 (ja)
KR (1) KR100476606B1 (ja)
CN (1) CN1146565C (ja)
AP (1) AP2001002349A0 (ja)
AR (1) AR033331A1 (ja)
AT (1) ATE244239T1 (ja)
AU (1) AU767334B2 (ja)
BG (1) BG65240B1 (ja)
BR (1) BR0011094A (ja)
CA (1) CA2372238C (ja)
CO (1) CO5170463A1 (ja)
CY (1) CY2007011I1 (ja)
CZ (1) CZ295819B6 (ja)
DE (1) DE60003679T2 (ja)
DK (1) DK1181290T3 (ja)
DZ (1) DZ3050A1 (ja)
EA (1) EA003731B1 (ja)
EC (1) ECSP003508A (ja)
EE (1) EE200100656A (ja)
ES (1) ES2199825T3 (ja)
GT (1) GT200000087A (ja)
HK (1) HK1046284A1 (ja)
HN (1) HN2000000077A (ja)
HR (1) HRP20010904A2 (ja)
HU (1) HUP0201301A3 (ja)
IL (1) IL146406A0 (ja)
MA (1) MA26742A1 (ja)
MX (1) MXPA01012325A (ja)
MY (1) MY133508A (ja)
NO (1) NO20015848L (ja)
NZ (1) NZ515349A (ja)
OA (1) OA11956A (ja)
PA (1) PA8496101A1 (ja)
PE (1) PE20010209A1 (ja)
PL (1) PL196046B1 (ja)
PT (1) PT1181290E (ja)
SI (1) SI1181290T1 (ja)
SK (1) SK285820B6 (ja)
SV (1) SV2001000093A (ja)
TN (1) TNSN00120A1 (ja)
TR (1) TR200103473T2 (ja)
TW (1) TWI285204B (ja)
UA (1) UA66925C2 (ja)
UY (1) UY26176A1 (ja)
WO (1) WO2000073304A1 (ja)
YU (1) YU81101A (ja)
ZA (1) ZA200109775B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06008648A (es) * 2004-01-30 2006-09-04 Pfizer Prod Inc Composiciones farmaceuticas de antagonistas del receptor de neuroquinina y ciclodextrina y metodos para una tolerancia mejorada en el sitio de inyeccion.
SI1713504T1 (sl) * 2004-01-30 2017-10-30 Zoetis Services Llc Protimikrobni konzervansi za dosego večodmerne formulacije z uporabo beta-ciklodekstrinov za tekoče odmerne oblike
AU2005216706B2 (en) 2004-01-30 2007-11-29 Pfizer Products Inc. NK-1 receptor antagonists anesthesia recovery
AU2005210259A1 (en) * 2004-02-02 2005-08-18 Pfizer Products Inc. Process for preparation of 1-(2S,3S)-2-benzhydr yl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
WO2014144894A1 (en) * 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639A (zh) * 2019-12-16 2021-06-18 四川科瑞德凯华制药有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2103269C1 (ru) * 1991-05-31 1998-01-27 Пфайзер Инк. Производные хинуклидина или их фармацевтически приемлемые соли и фармацевтическая композиция
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
JP2003501354A (ja) 2003-01-14
UA66925C2 (uk) 2004-06-15
EP1181290B1 (en) 2003-07-02
AU767334B2 (en) 2003-11-06
BG65240B1 (bg) 2007-09-28
DZ3050A1 (fr) 2004-03-27
TWI285204B (en) 2007-08-11
AU4424800A (en) 2000-12-18
CY2007011I2 (el) 2010-07-28
DE60003679D1 (de) 2003-08-07
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
DE60003679T2 (de) 2004-05-27
HUP0201301A2 (en) 2002-08-28
HK1046284A1 (en) 2003-01-03
BR0011094A (pt) 2002-03-19
AP2001002349A0 (en) 2001-12-31
MA26742A1 (fr) 2004-12-20
KR20020010688A (ko) 2002-02-04
TR200103473T2 (tr) 2002-04-22
PL352716A1 (en) 2003-09-08
ES2199825T3 (es) 2004-03-01
SK17332001A3 (sk) 2002-07-02
EE200100656A (et) 2003-02-17
PA8496101A1 (es) 2002-07-30
PT1181290E (pt) 2003-09-30
ATE244239T1 (de) 2003-07-15
ECSP003508A (es) 2002-02-25
CZ20014269A3 (cs) 2002-04-17
NO20015848D0 (no) 2001-11-30
CA2372238A1 (en) 2000-12-07
CN1353711A (zh) 2002-06-12
YU81101A (sh) 2004-07-15
SV2001000093A (es) 2001-11-08
DK1181290T3 (da) 2003-09-29
CY2007011I1 (el) 2010-07-28
OA11956A (en) 2006-04-13
EP1181290A1 (en) 2002-02-27
UY26176A1 (es) 2000-12-29
BG106204A (en) 2002-07-31
CO5170463A1 (es) 2002-06-27
CN1146565C (zh) 2004-04-21
EA200101108A1 (ru) 2002-04-25
JP3830816B2 (ja) 2006-10-11
AR033331A1 (es) 2003-12-17
SK285820B6 (sk) 2007-09-06
EA003731B1 (ru) 2003-08-28
CZ295819B6 (cs) 2005-11-16
PL196046B1 (pl) 2007-11-30
GT200000087A (es) 2001-11-22
HN2000000077A (es) 2001-02-02
SI1181290T1 (en) 2003-12-31
ZA200109775B (en) 2002-11-28
HRP20010904A2 (en) 2003-02-28
WO2000073304A1 (en) 2000-12-07
NZ515349A (en) 2004-03-26
HUP0201301A3 (en) 2002-10-28
MY133508A (en) 2007-11-30
KR100476606B1 (ko) 2005-03-18
TNSN00120A1 (fr) 2005-11-10
CA2372238C (en) 2006-12-19
MXPA01012325A (es) 2002-07-22
PE20010209A1 (es) 2001-03-01

Similar Documents

Publication Publication Date Title
HUP0202100A2 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HUP0303398A3 (en) 1,2-dihydropyridine compounds, process for preparation of the same and use thereof and pharmaceutical compositions containing the same
HUP0104718A3 (en) Micronized eplerenone compositions, process for their preparation and use thereof for the preparation of pharmaceutical compositions
HUP0203142A3 (en) Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0303524A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same and their use
HUP0204245A3 (en) Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0204515A3 (en) 4-aminopiperidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0200309A2 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression, process for their preparation and pharmaceutical compositions containing them
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP0202075A3 (en) Substituted 2-dialkylaminoalkylbiphenyl derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
AU2001258677A1 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
HUP0101043A3 (en) Controlled release oral dosage form containing [r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2]oct-3-yl]acetonitrile monohydrochlorid and process for its preparation
HUP0203471A3 (en) Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
HUP0105054A3 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
IL146406A0 (en) Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0102895A2 (hu) Ciklopentanon-dihidropiridin-származékok, alkalmazásuk gyógyszerkészítmények előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
HUP0202371A3 (en) Diacylhydrazine derivatives, process for producing them, use of these derivatives for producing of pharmaceutical compositions and pharmaceutical compositions
HUP0001712A3 (en) 2,3-methano-amino acid derivatives, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees